Comorbidities and Outcomes

Diabetes 2009 cohort, diabetes 2016 cohort, antihypertensive cohort, gout, heart failure, stroke, valvular heart disease, cardio-metabolic outcomes in PD-1/PD-L1 use. Anonymized datasets for research purposes (datasets last modified 1st Sept 2019).

Disclaimer: These datasets were generated during the course of academic research conducted at the Faculty of Medicine, The Chinese University of Hong Kong, which received ethics approval by The Joint Chinese University of Hong Kong – New Territories East Cluster Clinical Research Ethics Committee and/or the Institutional Review Board of the University of Hong
Kong/Hospital Authority Hong Kong West Cluster of the Hospital Authority. They have been anonymised and are published for further advancement of medical research in full compliance with University Regulations and Policy on Dataset Deposit and Sharing. Access is for research purposes only.

For additional information on local academic data deposition policies, see:

https://libguides.lib.cuhk.edu.hk/RDM/dataset_deposit

https://hub.hku.hk/researchdata/data.htm

The use of these datasets should provide acknowledgements of such efforts by citing this DOI.